Jungyoon Ohn

1.3k citations
50 papers · 920 indexed · h-index 16

Jungyoon Ohn

49 papers receiving 901 citations

Peers

Jungyoon Ohn
Comparison fields: 5 of 96
  • Dermatology 358
  • Immunology and Allergy 171
  • Pharmaceutical Science 129
  • Urology 81
  • Physiology 218
Replace Giselle Singer with:
Giselle Singer United States
Efstratios Vakirlis Greece
Till Assmann Germany
Francesca Farnetani Italy
Steven Kempers United States
Anthony du Vivier United Kingdom
Silvana Ciardo Italy
So‐Hyang Chung South Korea
Eun Joo Park South Korea
Dario Didona Italy
Jungyoon Ohn relative to Giselle Singer United States Giselle Singer's profile →
Citations per field
00.5×5.2×
Giselle Singer · 1×
Citations per year

Countries citing papers authored by Jungyoon Ohn

Since Specialization
Citations

This map shows the geographic impact of Jungyoon Ohn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jungyoon Ohn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jungyoon Ohn more than expected).

Fields of papers citing papers by Jungyoon Ohn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jungyoon Ohn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jungyoon Ohn. The network helps show where Jungyoon Ohn may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Jungyoon Ohn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jungyoon Ohn Line = papers co-authored together Jungyoon Ohn links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20230
2 202210
3 20224
4 20228
5 202218
6 20214
7 202136
8 20206
9 202014
10 20208
11 202027
12 202011
13 20192
14 201930
15 20174
16 20178
17 20177
18 20164
19 200543
20
TREATMENT OF ALLERGIC ASTHMA WITH MONOCLONAL ANTI-IgE ANTIBODY
1999236

About Jungyoon Ohn

Jungyoon Ohn is a scholar working on Dermatology, Urology and Immunology and Allergy, having authored 50 papers that have together received 920 indexed citations. Recurring topics across this work include Nail Diseases and Treatments (14 papers), Cutaneous lymphoproliferative disorders research (11 papers), Hair Growth and Disorders (8 papers), Dermatology and Skin Diseases (8 papers), Allergic Rhinitis and Sensitization (6 papers), Cutaneous Melanoma Detection and Management (6 papers), Infectious Diseases and Mycology (5 papers) and Plant Pathogens and Fungal Diseases (5 papers). The work is most often cited by research in Dermatology (358 citations), Immunology and Allergy (171 citations) and Pharmaceutical Science (129 citations). Jungyoon Ohn has collaborated with scholars based in South Korea, United States and Ethiopia. Frequent co-authors include Je‐Ho Mun, Ohsang Kwon, Kyu Han Kim, S Tudy G Roup, Bo Mi Kang, Mingyu Jang, Huisuk Yang, Hyungil Jung, Soyun Cho and Gwanghyun Jo. Their work appears in journals such as Journal of the American Academy of Dermatology, Scientific Reports, Journal of Dermatological Science, Journal of the European Academy of Dermatology and Venereology and The Journal of Dermatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026